Vivus Obesity Drug Market Is Very Large, Tam Says

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 18 (Bloomberg) -- Peter Tam, president of Vivus Inc., talks about the U.S. Food and Drug Administration's approval of the company's obesity drug Qsymia. He speaks with Adam Johnson on Bloomberg Television's "Street Smart." Barry Ritholtz, chief executive officer of FusionIQ, also speaks. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change